PAM
CYTR

Panagora Asset Management’s CytRx Corp CYTR Stock Holding History

Panagora Asset Management’s Portfolio CYTR Stock Details CYTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-5,475
Closed -$115K – 2496
2014
Q1 		$115K Buy
+5,475
New +$194K ﹤0.01% 1904

Other funds holding CYTR

QF
QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return

Panagora Asset Management's CYTR Position: Q2 2014 in Review

Panagora Asset Management sold out of CytRx Corp (CYTR) in Q2 2014, closing a stake of 5,475 shares — an estimated $115K sold.

Panagora Asset Management first reported a position in CYTR in Q1 2014 and held it in 1 quarter. The position peaked at $115K in Q1 2014. 74 funds tracked by Wall St. Rank hold CYTR as of Q2 2014.

  • Panagora Asset Management reported no remaining CytRx Corp position as of Q2 2014 after selling out during the quarter.
  • Panagora Asset Management sold 5,475 CytRx Corp shares in Q2 2014, an estimated $115K.
  • Panagora Asset Management first reported a position in CytRx Corp in Q1 2014 and held it in 1 quarter.
  • Panagora Asset Management's CytRx Corp position peaked at $115K in Q1 2014.
  • 74 funds tracked by Wall St. Rank held CytRx Corp as of Q2 2014.

Based on Panagora Asset Management's 13F filing for Q2 2014, filed 14 Aug 2014.